Moneycontrol PRO
HomeNewsBusinessAbbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

April 12, 2021 / 21:02 IST
_pharmaceuticals_190_75872574

_pharmaceuticals_190_75872574

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Abbott India to report net profit at Rs. 172.8 crore up 55.7% year-on-year (down 2.4% quarter-on-quarter).

Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Apr 12, 2021 09:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347